32 related articles for article (PubMed ID: 23800622)
21. Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer.
Falanga A; Schieppati F; Russo D
Semin Thromb Hemost; 2015 Oct; 41(7):756-64. PubMed ID: 26408922
[TBL] [Abstract][Full Text] [Related]
22. Update on tumor cell procoagulant factors.
Gale AJ; Gordon SG
Acta Haematol; 2001; 106(1-2):25-32. PubMed ID: 11549774
[TBL] [Abstract][Full Text] [Related]
23. Decreasing Tumor Growth and Angiogenesis by Inhibition of Coagulation.
Nadir Y
Semin Thromb Hemost; 2019 Sep; 45(6):622-628. PubMed ID: 31398734
[TBL] [Abstract][Full Text] [Related]
24. Heparanase procoagulant activity is elevated in women using oral contraceptives.
Matan M; Axelman E; Brenner B; Nadir Y
Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
[TBL] [Abstract][Full Text] [Related]
25. Heparanase procoagulant activity in cancer progression.
Nadir Y; Brenner B
Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
[TBL] [Abstract][Full Text] [Related]
26. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
27. Heparanase in the Coagulation System.
Nadir Y
Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
[TBL] [Abstract][Full Text] [Related]
28. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
29. Heparanase multiple effects in cancer.
Nadir Y; Brenner B
Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
